These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 6393261

  • 1. [The efficacy of prostacyclin (PGI2) and/or OKY-046, a specific thromboxane synthetase inhibitor, in acute myocardial infarction--experimental study].
    Moriuchi M.
    Kokyu To Junkan; 1984 Sep; 32(9):955-61. PubMed ID: 6393261
    [No Abstract] [Full Text] [Related]

  • 2. Selective thromboxane synthetase inhibitor and ischemic heart disease.
    Ito T, Ogawa K, Watanabe J, Chen LS, Shikano M, Imaizumi M, Shibata T, Ito Y, Miyazaki Y, Satake T.
    Biomed Biochim Acta; 1984 Sep; 43(8-9):S125-32. PubMed ID: 6542777
    [No Abstract] [Full Text] [Related]

  • 3. Development of an experimental model of acute myocardial infarction and the effects of a thromboxane synthetase inhibitor (OKY-046).
    Tomoda H.
    Am Heart J; 1986 Oct; 112(4):696-704. PubMed ID: 3532743
    [Abstract] [Full Text] [Related]

  • 4. [Protective effect of a thromboxane synthetase inhibitor, OKY-046, in patients with acute respiratory failure].
    Sakio H, Usui Y, Mita H, Onoda N, Iida M, Okuda C.
    Masui; 1984 Sep; 33(9):964-9. PubMed ID: 6542601
    [No Abstract] [Full Text] [Related]

  • 5. Application of prostacyclin analogue and thromboxane synthetase inhibitor to chronic vascular rejection after kidney transplantation.
    Teraoka S, Takahashi K, Toma H, Sanaka T, Yamaguchi Y, Tanabe K, Sato H, Kawaguchi H, Oba S, Nakajima I.
    Transplant Proc; 1987 Oct; 19(5):3664-8. PubMed ID: 3313883
    [No Abstract] [Full Text] [Related]

  • 6. Effects of selective thromboxane synthetase inhibitor OKY-046 on plasma prostaglandins in patients with coronary artery disease during exercise.
    Shikano M, Ogawa K, Ito T, Chen LS, Ito Y, Imaizumi M, Uno T, Tsutsumi S, Satake T.
    Adv Prostaglandin Thromboxane Leukot Res; 1985 Oct; 13():375-7. PubMed ID: 3159226
    [No Abstract] [Full Text] [Related]

  • 7. [Experimental study on the prevention of vasospasm following subarachnoid hemorrhage by a thromboxane A2 synthetase inhibitor, OKY-046].
    Ohsugi S.
    Nihon Geka Hokan; 1986 Mar 01; 55(2):297-305. PubMed ID: 3827476
    [No Abstract] [Full Text] [Related]

  • 8. Augmented thromboxane A2 generation and efficacy of its blockade in acute myocardial infarction.
    Tada M, Hoshida S, Kuzuya T, Inoue M, Minamino T, Abe H.
    Int J Cardiol; 1985 Jul 01; 8(3):301-12. PubMed ID: 4040500
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the thromboxane synthetase inhibitor dazoxiben and the prostacyclin mimetic iloprost in an animal model of acute ischaemia and reperfusion.
    Thiemermann C, Schrör K.
    Biomed Biochim Acta; 1984 Jul 01; 43(8-9):S151-4. PubMed ID: 6083783
    [Abstract] [Full Text] [Related]

  • 10. Endogenous prostacyclin contributes to the efficacy of a thromboxane synthetase inhibitor for preventing coronary artery thrombosis.
    Aiken JW, Shebuski RJ, Miller OV, Gorman RR.
    J Pharmacol Exp Ther; 1981 Nov 01; 219(2):299-308. PubMed ID: 6270303
    [No Abstract] [Full Text] [Related]

  • 11. Stimulation of vessel wall prostacyclin by selective thromboxane synthetase inhibitor OKY 1581.
    Mehta J, Mehta P, Ostrowski N.
    Prostaglandins Leukot Med; 1983 Sep 01; 12(1):49-52. PubMed ID: 6356153
    [Abstract] [Full Text] [Related]

  • 12. The role of the prostacyclin-thromboxane system in cerebral vasospasm following induced subarachnoid hemorrhage in the rabbit.
    Chan RC, Durity FA, Thompson GB, Nugent RA, Kendall M.
    J Neurosurg; 1984 Dec 01; 61(6):1120-8. PubMed ID: 6389786
    [Abstract] [Full Text] [Related]

  • 13. [Analogs of prostaglandin-related substances and inhibitors of their synthesis and metabolism. Clinical application: cardiovascular diseases].
    Ogawa K, Ito T.
    Nihon Rinsho; 1985 Mar 01; 43(3):578-82. PubMed ID: 3892088
    [No Abstract] [Full Text] [Related]

  • 14. Prostacyclin and thromboxane in cerebral vasospasm II: Effects of thromboxane synthetase inhibitor (OKY-1581) on experimentally-induced cerebral vasospasm.
    Yabuno N.
    Acta Med Okayama; 1984 Jun 01; 38(3):239-50. PubMed ID: 6380217
    [Abstract] [Full Text] [Related]

  • 15. In vivo inhibition of thromboxane synthetase in infarcted canine myocardium.
    McCluskey ER, Kramer JB, Corr PB, Needleman P.
    Biochem Biophys Res Commun; 1984 Jun 15; 121(2):552-7. PubMed ID: 6539597
    [Abstract] [Full Text] [Related]

  • 16. Cardioprotective actions of a selective thromboxane synthetase inhibitor in acute myocardial ischemia.
    Burke SE, Lefer DJ, Lefer AM.
    Arch Int Pharmacodyn Ther; 1983 Sep 15; 265(1):76-84. PubMed ID: 6686001
    [Abstract] [Full Text] [Related]

  • 17. Pharmacological studies on OKY-1581: a selective thromboxane synthetase inhibitor.
    Hiraku S, Wakitani K, Katsube N, Kawasaki A, Tsuboshima M, Naito J, Ujiie A, Komatsu H, Iizuka K.
    Adv Prostaglandin Thromboxane Leukot Res; 1983 Sep 15; 11():241-4. PubMed ID: 6221530
    [No Abstract] [Full Text] [Related]

  • 18. [Effects of a selective thromboxane A2 synthetase inhibitor, OKY-046, on proteinuria of aminonucleoside nephrotic rats].
    Suzuki S, Akama H, Kume K, Higuchi E, Kamiyama S, Suzuki J, Ohara N, Yugeta E, Kato K, Suzuki H.
    Nihon Jinzo Gakkai Shi; 1988 Apr 15; 30(4):341-6. PubMed ID: 3230687
    [No Abstract] [Full Text] [Related]

  • 19. Clinical study on effect of thromboxane A2 synthetase inhibitor (OKY-046) to clarify the regulation of cerebral blood flow in cerebral thrombosis.
    Nihei C, Metoki H, Shimanaka Y, Kawahara R, Komatsu O, Oike Y, Kanazawa T, Izawa M, Kaneko H, Hoshi Y.
    Adv Prostaglandin Thromboxane Leukot Res; 1987 Apr 15; 17B():953-7. PubMed ID: 2960210
    [No Abstract] [Full Text] [Related]

  • 20. Prevention of endotoxin-induced pulmonary hypertension in primates by the use of a selective thromboxane synthetase inhibitor, OKY 1581.
    Casey LC, Fletcher JR, Zmudka MI, Ramwell PW.
    J Pharmacol Exp Ther; 1982 Aug 15; 222(2):441-6. PubMed ID: 6896528
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.